2020 American Transplant Congress
Limited Differences in Infectious Complications of Pediatric Liver Transplant between Hepatoblastoma and Non-Hepatoblastoma Patients
Cincinnati Children's Hosp Med Cntr, Cincinnati, OH
*Purpose: Pediatric liver transplantation (pLTX) has become a part of treatment for Hepatoblastoma (HB). The incidence and characterization of infectious events (IE) has not been…2020 American Transplant Congress
Evaluation of the Safety and Efficacy of Valganciclovir to Prevent Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients Utilizing Two Dosing Regimens
Pharmacy, Ann and Robert H. Lurie Children's Hospital, Chicago, IL
*Purpose: Valganciclovir (VGCV) is FDA-approved for CMV prophylaxis in children aged one month to sixteen years old using the Pescovitz algorithm (7 x body surface…2020 American Transplant Congress
Efficacy and Safety of Single-Dose Rabbit Anti-Thymocyte Globulin versus Basiliximab Induction among Pediatric Kidney Transplant Recipients
Hospital do Rim, Sao Paulo, Brazil
*Purpose: Induction therapy is a standard component of kidney transplant immunosuppression protocols. However, in the pediatric population, there are still uncertainties about the ideal induction…2020 American Transplant Congress
Taking on Pediatric Liver Tumors – Beyond Hepatoblastoma
MedStar Georgetown Transplant Institute, Washington, DC
*Purpose: Background. Hepatic angiosarcomas, hepatocellular carcinoma, hemangioendothelioma, and rhabdomyosarcoma of the bile ducts are very rare tumors in children with historically poor prognosis. Median survival…2020 American Transplant Congress
The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is it Time to Split the Difference?
*Purpose: The opioid epidemic afflicting our nation has led to a surge in the number of adult deceased donors from drug overdose. We hypothesized that…2020 American Transplant Congress
A Population-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment
*Purpose: Hepatocellular carcinoma (HCC) constitutes 0.5% of childhood malignancies and exhibits poor prognosis. Complete tumor extirpation either by partial liver resection (LR) or liver transplantation…2020 American Transplant Congress
Plasma Microbiome Profiles of Liver Transplant Patients with Operational Tolerance
*Purpose: Microbiome has emerged as a key modulator of organ homeostasis and immune system function with altered microbiota and microbiome - host interactions contributing to…2020 American Transplant Congress
Social Determinants as Indicators for Medication Adherence and Graft Function in Pediatric Kidney Transplant Recipients
Oregon Health & Science Univ, Portland, OR
*Purpose: To examine the association of social determinants of health (SDoH), the conditions in which people are born and live, with medication adherence and graft…2020 American Transplant Congress
Efficacy and Tolerability of Tedizolid Phosphate in the Treatment of Mycobacterium Abscessus Infection among Pediatric Hematopoietic Stem Cell Transplant Recipients
Pediatrics, UT Southwestern Medical Center, Dallas, TX
*Purpose: Mycobacterium abscessus complex infections are associated with high rates of morbidity and mortality in immunocompromised hosts. Treatment can be challenging due to broad spectrum…2020 American Transplant Congress
Adult Liver Transplant Recipients Show Increased Fibrinolysis Resistance Compared with Pediatric Recipients: The Potential Impact of Anticoagulation between the Two Populations
University of Colorado, Aurora, CO
*Purpose: Fibrinolytic changes in adult liver transplant patients have previously been demonstrated large transitions from excessive fibrinolysis (hyperfibrinolysis) to fibrinolysis resistance (shutdown) within 2 hours…
- « Previous Page
- 1
- …
- 21
- 22
- 23
- 24
- 25
- …
- 64
- Next Page »